Gönen, M., Sun, Z., Figueroa, M. E., Patel, J. P., Abdel-Wahab, O., Racevskis, J., . . . Paietta, E. (2012). CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. American Society of Hematology.
Citação norma ChicagoGönen, Mithat, et al. CD25 Expression Status Improves Prognostic Risk Classification in AML Independent of Established Biomarkers: ECOG Phase 3 Trial, E1900. American Society of Hematology, 2012.
Citação norma MLAGönen, Mithat, et al. CD25 Expression Status Improves Prognostic Risk Classification in AML Independent of Established Biomarkers: ECOG Phase 3 Trial, E1900. American Society of Hematology, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.